Literature DB >> 7217717

Primary amoebic meningoencephalitis: a report of two cases and antibiotic and immunologic studies.

A R Stevens, S T Shulman, T A Lansen, M J Cichon, E Willaert.   

Abstract

In the summer of 1978, two children who had recently been swimming in freshwater lakes in Florida died from primary amoebic meningoencephalitis. Despite early and intensive treatment with amphotericin B, both patients died three to five days after the onset of illness. Amoebae were observed in wet preparations of cerebrospinal fluid and in sections of cerebral tissue and were identified as Naegleria fowleri by the indirect immunofluorescent antibody technique. The amoebae were highly virulent in mice. The isolate of N. fowleri was extremely sensitive in vitro to amphotericin B (minimal inhibitory concentration [MIC], 0.15 microgram/ml), somewhat sensitive to miconazole (MIC, 25 micrograms/ml), and resistant to rifampin (MIC, less than or equal to 100 micrograms/ml). Treatment with amphotericin B (7.5 mg/kg of body weight per day) administered intraperitoneally protected 60% of the mice. Lower doses of amphotericin B alone or in combination with miconazole (100 mg/kg) or rifampin (220 mg/kg) were not protective. These results suggest that amphotericin B remains the single effective agent in treatment of primary amoebic meningoencephalitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7217717     DOI: 10.1093/infdis/143.2.193

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

2.  Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae.

Authors:  F L Schuster; N Mandel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 3.  Naegleria fowleri: pathogenesis, diagnosis, and treatment options.

Authors:  Eddie Grace; Scott Asbill; Kris Virga
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

4.  Vaccination with lentiviral vector expressing the nfa1 gene confers a protective immune response to mice infected with Naegleria fowleri.

Authors:  Jong-Hyun Kim; Hae-Jin Sohn; Jinyoung Lee; Hee-Jong Yang; Yong-Joon Chwae; Kyongmin Kim; Sun Park; Ho-Joon Shin
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

5.  Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri.

Authors:  Jong-Hyun Kim; Suk-Yul Jung; Yang-Jin Lee; Kyoung-Ju Song; Daeho Kwon; Kyongmin Kim; Sun Park; Kyung-Il Im; Ho-Joon Shin
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

6.  Use of monoclonal antibodies to distinguish pathogenic Naegleria fowleri (cysts, trophozoites, or flagellate forms) from other Naegleria species.

Authors:  O Sparagano; E Drouet; R Brebant; E Manet; G A Denoyel; P Pernin
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

7.  Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Goswick; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Isolation of Acanthamoeba culbertsoni from a patient with meningitis.

Authors:  M K Lalitha; V Anandi; A Srivastava; K Thomas; A M Cherian; S M Chandi
Journal:  J Clin Microbiol       Date:  1985-04       Impact factor: 5.948

9.  Isolation of two strains of Acanthamoeba castellanii from human tissue and their pathogenicity and isoenzyme profiles.

Authors:  G S Visvesvara; S S Mirra; F H Brandt; D M Moss; H M Mathews; A J Martinez
Journal:  J Clin Microbiol       Date:  1983-12       Impact factor: 5.948

10.  Inhibition of Naegleria fowleri by microbial iron-chelating agents: ecological implications.

Authors:  A L Newsome; W E Wilhelm
Journal:  Appl Environ Microbiol       Date:  1983-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.